HomePress-release
Redding, California - November 30, 2022

Radiation Dose Management Market Worth $749.1 Million by 2029

Radiation Dose Management Market by Solution & Service, Modality (CT, Nuclear Medicine, Fluoroscopy, Mammography), Application (Oncology, Cardiology, Orthopedic, Neurology), End User (Hospitals, Ambulatory Care Setting) - Global Forecast to 2029


Meticulous Research®—a leading global market research company, published a research report titled, Radiation Dose Management Market by Solution & Service, Modality (CT, Nuclear Medicine, Fluoroscopy, Mammography), Application (Oncology, Cardiology, Orthopedic, Neurology), End User (Hospitals, Ambulatory Care Setting) - Global Forecast to 2029.’

According to this latest publication from Meticulous Research®, the global radiation dose management market is projected to reach $749.1 million by 2029, at a CAGR of 13.3% during the forecast period. The increasing use of diagnostic imaging modalities, surge in concerns regarding radiation exposure, and increasing awareness about radiation dose management are the factors driving the growth of this market.

Radiation Dose Management Market: Future Outlook

The global radiation dose management market is segmented by Offering (Solutions, Services), Modality (Computed Tomography, Fluoroscopy & Interventional Imaging, Nuclear Medicine, Radiography & Mammography), Application (Oncology, Cardiology, Orthopedics, Neurology, Other Applications), and End User (Ambulatory Care Settings, Hospitals, Other End Users). The study also evaluates industry competitors and analyzes their market shares at the regional and country levels.

Based on offering, in 2022, the solutions segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the high adoption of radiation dose management solutions, high prevalence of target diseases, and increased awareness and regulations for ionizing radiation.

Based on modality, the radiation dose management market is segmented into computed tomography, fluoroscopy & interventional imaging, nuclear medicine, radiography & mammography. In 2022, the computed tomography segment is expected to account for the largest share of the market due to an increase in early disease diagnosis and the preference for non-invasive diagnostic procedures leading to increased computed tomography examinations.

Based on application, the radiation dose management market is segmented into oncology, cardiology, orthopedics, neurology, and other applications. In 2022, the oncology segment is expected to account for the largest share of the market, owing to the high burden of cancer and increased usage of imaging modalities in oncology.

Based on end user, in 2022, the hospital segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the high patient inflow in the hospitals compared to other healthcare settings for the diagnosis and treatment of diseases.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa. In 2022, North America is expected to account for the largest share of the radiation dose management market. The large share of this regional market is driven by the high prevalence of cancer, high diagnosis rate, high healthcare spending, increased awareness of harmful effects of radiation exposure, and the presence of guidelines regulating the exposure of the same.

The key players operating in the global radiation dose management market are Bayer AG (Germany), Siemens Healthineers GmbH (Germany), Bracco Imaging S.p.A. (Italy), FUJIFILM Holdings Corporation (Japan), GE Healthcare (U.S.), Medsquare (France), Novarad Corporation (U.S.), PACSHealth, LLC (U.S.), Koninklijke Philips N.V. (Netherlands), Qaelum N.V. (Belgium), Sectra AB (Sweden), Agfa Healthcare (Belgium), Canon Inc. (Japan), Guerbet (France), Medic Vision (U.S.), and Volpara Health Limited (U.S.).

Download Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5394

Key questions answered in the report-

  • Which are the high-growth market segments in terms of offering, modality, application, end user, and regions/countries?
  • What was the historical market for radiation dose management across the globe?
  • What are the market forecasts and estimates for the period 2022–2029?
  • What are the major drivers, restraints, challenges, opportunities, and trends in the global radiation dose management market?
  • Who are the major players in the global radiation dose management market?
  • How is the competitive landscape, and who are the market leaders in the global radiation dose management market?
  • What are the recent developments in the radiation dose management market?
  • What are the different strategies adopted by the major players in the radiation dose management market?
  • What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Recommended Readings

  Download Free Sample
Table Of Content
Download Free Sample Report